Haohai Biological Technology: One of the controlling shareholders and actual controllers, Jiang Wei, received the “Decision on Bail Pending Investigation” for matters unrelated to this company.

robot
Abstract generation in progress
Haohai Biological Technology Announcement, the company recently received a notice from Mr. Jiang Wei, one of the controlling shareholders and actual controllers, that due to an investigation related to suspected insider trading, the Shanghai Public Security Bureau issued a "Decision on Bail Pending Trial," deciding to release Mr. Jiang Wei on bail pending trial, with the period starting from April 29, 2026. Previously, Mr. Jiang Wei had received an "Administrative Penalty Decision" (No. [2025]151) issued by the China Securities Regulatory Commission in December 2025 for insider trading and other behaviors. The aforementioned matters are unrelated to the company, and Mr. Jiang Wei has not served as a director, senior management personnel, or in any other position at the company. This matter will not have a significant impact on the company's daily operations.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned